Immunogenicity and Cross-Reactivity of 2009–2010 Inactivated Seasonal Influenza Vaccine in US Adults and Elderly
2011

Immunogenicity of 2009–2010 Seasonal Influenza Vaccine in US Adults and Elderly

Sample size: 179 publication 10 minutes Evidence: moderate

Author Information

Author(s): Xie Hang, Jing Xianghong, Li Xing, Lin Zhengshi, Plant Ewan, Zoueva Olga, Yang Hong, Ye Zhiping

Primary Institution: United States Food and Drug Administration

Hypothesis

How does the 2009–2010 seasonal influenza vaccine affect antibody responses in adults and the elderly?

Conclusion

The 2009–2010 seasonal influenza vaccine significantly boosted antibody responses in both adults and the elderly, particularly against pandemic H1N1 strains.

Supporting Evidence

  • Over 70% of recipients reached a seroprotective titer of 40 against seasonal strains after vaccination.
  • 24% of adults and 36% of elderly reached a seroprotective titer against pandemic H1N1 after vaccination.
  • 22% of adults and 34% of elderly showed a 4-fold increase in HAI titers against pandemic H1N1 after vaccination.

Takeaway

The flu shot helped people make more antibodies to fight the flu, especially older folks.

Methodology

The study used hemagglutination inhibition (HAI) assays to evaluate antibody responses before and after vaccination in healthy adults and elderly participants.

Potential Biases

Potential bias due to observational study design and reliance on self-reported vaccination status.

Limitations

The study did not evaluate the long-term effectiveness of the vaccine against the pandemic strain.

Participant Demographics

120 adults aged 20.1–64.8 years and 59 elderly aged 65.4–88.2 years.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0016650

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication